What is this?

HISWAI shows you what’s connected to topics that interest you, and where to find more. HISWAI members can curate information with dashboards to gain insights, proper context and stay up to date on the latest relevant information. Sharing these discoveries with others is easy too!

help

Want to know more?

Tag: Pertuzumab

Tag Visualization: Top 50 related tags by occurrence

Recent Articles

Study confirms benefit of breast cancer drug: AstraZeneca - ARY News
Check Sources

2022-08-15 12:47:52

Clinical medicine
Medicine
Cancer
Genentech
Cancer treatments
Antineoplastic drugs
RTT
Breast cancer
HER2/neu
Metastatic breast cancer
AstraZeneca
Pertuzumab
Daiichi Sankyo
AstraZeneca shares rise after trial success of its breast cancer drug | This is Money
Check Sources

2022-08-15 12:27:52

Clinical medicine
Medicine
Cancer
Breast cancer
RTT
Genentech
Metastatic breast cancer
AstraZeneca
HER2/neu
Pertuzumab
Trastuzumab emtansine
FTSE 100 Index
astrazeneca as
What's Happening With Roche (RHHBY) Stock? - Forbes
Check Sources

2022-09-30 18:34:28

Genentech
Drugs
Life Sciences
Biotechnology
Hoffmann-La Roche
Monoclonal antibodies
Roche
Trastuzumab emtansine
Pertuzumab
Roche Group
S&P 500 INDEX - CBOE
Roche Q3 Pharma Revenues Decline 6 Percent Due to Lower Sales of COVID-19 Treatments
Check Sources

2022-10-18 18:38:56

Genentech
Clinical medicine
Medicine
Health
Pertuzumab
Trastuzumab emtansine
Trastuzumab
HER2/neu
Hoffmann-La Roche
Atezolizumab
Triple-negative breast cancer
Breast cancer
Roche Group
William Anderson
Insights Into The Global Cancer Monoclonal Antibodies Market 2022-2030 Forecast Period
Check Sources

2022-11-16 01:53:52

Medical specialties
Life Sciences
Monoclonal antibodies
Medicine
Immunology
Biotechnology
Immune system
Biopharmaceutical
Antibody
Humanized antibody
Pertuzumab
Monoclonal antibody therapy
Business Research Company
AstraZeneca aims to redefine breast cancer care with new data across the treatment ... - Cision News
Check Sources

2022-11-22 07:05:45

Clinical medicine
Drugs
Medicine
Genentech
Breast cancer
RTT
Antineoplastic drugs
Monoclonal antibodies
Trastuzumab emtansine
Pertuzumab
HER2/neu
Triple-negative breast cancer
CORRECT: AstraZeneca cancer drug shows encouraging results in trial - Morningstar
Check Sources

2022-12-09 15:06:10

Clinical medicine
Medicine
Cancer
Genentech
Breast cancer
Cancer treatments
RTT
Protein kinase inhibitors
HER2/neu
Metastatic breast cancer
Tucatinib
Pertuzumab
AstraZeneca plc
Daiichi Sankyo Co Ltd
AstraZeneca cancer drug shows encouraging results in phase 1 trial - shareprices.com
Check Sources

2022-12-09 14:52:20

Clinical medicine
Medicine
Cancer
Genentech
Cancer treatments
Breast cancer
RTT
HER2/neu
Metastatic breast cancer
Tucatinib
Pertuzumab
AstraZeneca plc
Daiichi Sankyo Co Ltd
Alliance News Ltd.
Systemic Therapy for Brain Metastasis in Advanced HER2+ Breast Cancer | Mirage News
Check Sources

2023-09-13 18:21:28

Antineoplastic drugs
Immunology
Antibody-drug conjugates
Cancer treatments
Breakthrough therapy
HER2
Trastuzumab deruxtecan
Trastuzumab
Antibody-drug conjugate
Breast cancer
Pertuzumab
Trastuzumab emtansine
Clinical Trial: Atezolizumab Plus Trastuzumab Emtansine in HER2+ Breast Cancer
Check Sources

2023-09-28 15:18:21

Trastuzumab emtansine
Cancer treatments
Antineoplastic drugs
Immunology
HER2
Trastuzumab
Breast cancer
Atezolizumab
Mertansine
Genentech
Pertuzumab
HOFFMANN - LA ROCHE